Benznidazole
From Wikipedia, the free encyclopedia
Benznidazole
|
|
Systematic (IUPAC) name | |
N-benzyl-2-(2-nitroimidazol-1-yl)acetamide | |
Identifiers | |
CAS number | 22994-85-0 |
ATC code | P01CA02 |
PubChem | 31593 |
Chemical data | |
Formula | C12H12N4O3 |
Mol. weight | 260.249 g/mol |
Pharmacokinetic data | |
Bioavailability | High |
Metabolism | Hepatic |
Half life | 12 hours |
Excretion | Renal and fecal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Oral |
Benznidazole (INN, marketed by Hoffman-La Roche under the trade names Rochagan® and Radanil®) is an antiparasitic medication used in the treatment of Chagas disease.
[edit] Side effects
The side effects most commonly associated with benznidazole therapy are rash and gastrointestinal symptoms such as nausea. Rarely, peripheral neuropathy may present after prolonged treatment.
[edit] External links
- (Portuguese) Rochagan® [Patient Information] (PDF). Hoffmann-La Roche. Retrieved on 2006-11-27.